These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3951332)

  • 1. Isolated rat cardiac myocytes as an experimental model to study calcium overload: the effect of calcium-entry blockers.
    Donck LV; Pauwels PJ; Vandeplassche G; Borgers M
    Life Sci; 1986 Mar; 38(9):765-72. PubMed ID: 3951332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of calcium antagonists on calcium overload contractures in embryonic chick myocytes induced by ouabain and veratrine.
    Patmore L; Duncan GP; Spedding M
    Br J Pharmacol; 1989 May; 97(1):83-94. PubMed ID: 2470461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the cardiac and vasodilatory effects of some calcium entry blockers in perfused isolated guinea-pig hearts.
    Boddeke HW; Wilffert B; Heynis JB; van de Haar Keuken V; Jonkman FA; van Zwieten PA
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):175-85. PubMed ID: 3675080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of lidoflazine and mioflazine against potassium and veratrine induced shape changes in isolated rat cardiac myocytes.
    Ver Donck L; Liu GS; Vandeplassche G; Borgers M
    Basic Res Cardiol; 1987; 82(1):74-81. PubMed ID: 3593184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium entry blockers and vascular smooth muscle heterogeneity.
    Van Nueten JM; Vanhoutte PM
    Fed Proc; 1981 Dec; 40(14):2862-5. PubMed ID: 7308496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the mechanism of negative inotropic activity of some calcium antagonists.
    Boddeke HW; Wilffert B; Heynis JB; van Zwieten PA
    J Cardiovasc Pharmacol; 1988 Mar; 11(3):321-5. PubMed ID: 2452925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of cardiomyocytes.
    Borgers M; Ver Donck L; Vandeplassche G
    Ann N Y Acad Sci; 1988; 522():433-53. PubMed ID: 3288055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class IV Ca2+ antagonists do not affect lipid peroxidation in singlet oxygen challenged cardiomyocytes.
    Ver Donck L; Verellen G; Vandewiele R; De Clerck F; Borgers M
    Cell Biol Int Rep; 1990 Apr; 14(4):399-406. PubMed ID: 2354524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of calcium entry blockers in several models of immediate hypersensitivity.
    Ritchie DM; Sierchio JN; Bishop CM; Hedli CC; Levinson SL; Capetola RJ
    J Pharmacol Exp Ther; 1984 Jun; 229(3):690-5. PubMed ID: 6202868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of bepridil against veratrine-induced contracture in rat atria.
    Leboeuf J; Baissat J; Massingham R
    Eur J Pharmacol; 1992 Jun; 216(2):183-9. PubMed ID: 1397005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of negative inotropic potency, reversibility, and effects on calcium influx of six calcium channel antagonists in cultured myocardial cells.
    Barry WH; Horowitz JD; Smith TW
    Br J Pharmacol; 1985 May; 85(1):51-9. PubMed ID: 4027472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherosclerosis, calcium, and calcium antagonists.
    Henry PD
    Circulation; 1985 Sep; 72(3):456-9. PubMed ID: 3893790
    [No Abstract]   [Full Text] [Related]  

  • 13. Second-generation calcium antagonists: search for greater selectivity and versatility.
    Singh BN; Baky S; Nademanee K
    Am J Cardiol; 1985 Jan; 55(3):214B-221B. PubMed ID: 3155893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of Ca2+ channel blockers on Ca2+ overload induced by lysophosphatidylcholine in cardiomyocytes.
    Chen M; Xiao CY; Hashizume H; Abiko Y
    Eur J Pharmacol; 1997 Aug; 333(2-3):261-8. PubMed ID: 9314043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of calcium-entry blockers and divalent cations on noradrenaline-induced contractions of the rat anococcygeus muscle.
    Oriowo MA
    Arch Int Pharmacodyn Ther; 1984 Sep; 271(1):45-52. PubMed ID: 6497509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The differential effect of calcium antagonists on the positive inotropic effects induced by calcium and monensin in cardiac preparations of rats and guinea-pigs.
    Hugtenburg JG; Mathy MJ; Beckeringh JJ; van Zwieten PA
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):558-66. PubMed ID: 2615847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the calcium entry and calcium overload blocking properties of R71811 and flunarizine.
    Matsui Y; Yamagami I; Hirai K
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Sep; 342(3):264-70. PubMed ID: 2126346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium entry blockers: a review.
    Goad DL
    J Vet Pharmacol Ther; 1982 Dec; 5(4):233-9. PubMed ID: 6306265
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential influence of various calcium-modulating compounds on ouabain intoxication in isolated rat left atria.
    Wilhelm D; Scheufler E; Peters T
    Pharmacology; 1990; 41(6):316-26. PubMed ID: 1710808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
    Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.